Stocktoria
Cresco Labs Inc. CRLBF
OTC · OOTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2018-12-03
Cresco Labs Inc. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Gross margin | 49.5% | 50.3% | 47.0% |
| Operating margin | -4.3% | 14.8% | -11.4% |
| Net margin | -20.6% | -10.3% | -22.8% |
| FCF margin | 5.8% | 15.6% | 0.4% |
| Return on assets | -11.3% | -5.5% | -12.9% |
| Return on equity | -39.8% | -15.7% | -34.7% |
| Debt / equity | 1.23× | 0.97× | 0.98× |
| Current ratio | 2.59 | 3.12 | 1.39 |
Source: SEC EDGAR filings · CIK 0001832928 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.